SEPTEMBER - 20211TECH OUTLOOKSEPTEMBER - 20 - 2021$15www.pharmatechoutlook.comISSN 2644-2787VEEVA SYSTEMS (NYSE: VEEV)REDEFINING THE TENETS OF CLINICAL TRIAL ECOSYSTEMPeter Gassner, Co-Founder and CEO
Page 2 >